Finance

Lists
002390:SHE
Guizhou Xinbang Pharmaceutical Co Ltd
CN¥2.85
-1.72%
(-0.050) 1D
Oct 15, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002390...
Open
CN¥2.87
High
CN¥2.91
Low
CN¥2.83
Mkt. cap
5.70B
Avg. vol.
25.59M
Volume
26.66M
Dividend
3.16%
Quarterly dividend
CN¥0.02
Ex-dividend date
Sep 29, 2026
P/E ratio
47.77
52-wk high
CN¥4.15
52-wk low
CN¥2.54
EPS
CN¥0.06
Shares outstanding
1.94B
No. of employees
5K
Open
CN¥2.87
High
CN¥2.91
Low
CN¥2.83
Mkt. cap
5.70B
Avg. vol.
25.59M
Volume
26.66M
Dividend
3.16%
Quarterly dividend
CN¥0.02
Ex-dividend date
Sep 29, 2026
P/E ratio
47.77
52-wk high
CN¥4.15
52-wk low
CN¥2.54
EPS
CN¥0.06
Shares outstanding
1.94B
No. of employees
5K
News stories
From web sources and news partners
About Guizhou Xinbang Pharmaceutical Co Ltd
CEO-
Employees4.7K
FoundedJan 27, 1995
Headquarters-
SectorPharmaceutical industry
Websitexinbang.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.42B
1.35B
1.26B
1.20B
Cost of goods sold
1.17B
1.12B
1.06B
1.01B
Cost of revenue
1.17B
1.12B
1.06B
1.01B
Research and development expenses
1.28M
1.50M
1.95M
2.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151.56M
153.22M
121.62M
114.72M
Operating expense
175.60M
181.58M
127.31M
129.01M
Total operating expenses
1.34B
1.30B
1.19B
1.14B
Operating income
76.59M
54.46M
77.38M
65.80M
Other non operating income
-6.48M
-56.24M
259.61K
-5.96M
EBT including unusual items
65.97M
4.74M
76.27M
77.46M
EBT excluding unusual items
65.91M
16.58M
76.18M
74.99M
Income tax expense
7.64M
13.72M
11.71M
5.89M
Effective tax rate
11.57%
289.59%
15.36%
7.61%
Other operating expenses
17.06M
10.40M
5.92M
7.90M
Net income
45.13M
-32.04M
48.66M
50.93M
Net profit margin
3.18%
-2.37%
3.85%
4.23%
Earnings per share
-
-
-
-
Interest and investment income
1.56M
20.59M
1.86M
18.18M
Interest expense
-5.76M
-2.25M
-3.32M
-3.02M
Net interest expenses
-4.20M
18.35M
-1.45M
15.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.65M
102.75M
125.66M
112.94M
Gain or loss from assets sale
95.70K
3.48M
-
524.45K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps